Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB043A | — |
Menveo (orange cap vial-lyophilized) was mixed with sterile water diluent and administered to patient; Menveo (orange cap vial-lyophilized) was mixed with sterile water diluent and administered to patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB043A, expiry date 31-JUL-2025) for prophylaxis. On 03-MAR-2025, the patient received Menveo. On 03-MAR-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menveo (orange cap vial-lyophilized) was mixed with sterile water diluent and administered to patient) and inappropriate dose of vaccine administered (Verbatim: Menveo (orange cap vial-lyophilized) was mixed with sterile water diluent and administered to patient). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 05-MAR-2025 The reporter stated that on Monday, 3rd March 2025 Menveo (orange cap vial-lyophilized) was mixed with sterile water diluent and administered to a patient which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.